149 related articles for article (PubMed ID: 16241947)
1. A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis.
Komanasin N; Catto AJ; Futers TS; van Hylckama Vlieg A; Rosendaal FR; Ariëns RA
J Thromb Haemost; 2005 Nov; 3(11):2487-96. PubMed ID: 16241947
[TBL] [Abstract][Full Text] [Related]
2. Association of a common polymorphism in the factor XIII gene with venous thrombosis.
Catto AJ; Kohler HP; Coore J; Mansfield MW; Stickland MH; Grant PJ
Blood; 1999 Feb; 93(3):906-8. PubMed ID: 9920839
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Mezei ZA; Katona É; Kállai J; Bereczky Z; Molnár É; Kovács B; Ajzner É; Bagoly Z; Miklós T; Muszbek L
Thromb Res; 2016 Dec; 148():101-106. PubMed ID: 27821352
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
6. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding.
Ruigrok YM; Slooter AJ; Rinkel GJ; Wijmenga C; Rosendaal FR
Acta Neurochir (Wien); 2010 Feb; 152(2):257-62. PubMed ID: 19826759
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
Mezei ZA; Bereczky Z; Katona É; Gindele R; Balogh E; Fiatal S; Balogh L; Czuriga I; Ádány R; Édes I; Muszbek L
Int J Mol Sci; 2015 Jan; 16(1):1143-59. PubMed ID: 25569091
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII polymorphisms and venous thromboembolism.
Francis CW
Arch Pathol Lab Med; 2002 Nov; 126(11):1391-3. PubMed ID: 12421147
[TBL] [Abstract][Full Text] [Related]
10. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
Wells PS; Anderson JL; Rodger MA; Carson N; Grimwood RL; Doucette SP
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):533-8. PubMed ID: 16988547
[TBL] [Abstract][Full Text] [Related]
11. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Cushman M; Cornell A; Folsom AR; Wang L; Tsai MY; Polak J; Tang Z
Thromb Res; 2007; 121(3):339-45. PubMed ID: 17582472
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Mezei ZA; Katona É; Kállai J; Bereczky Z; Somodi L; Molnár É; Kovács B; Miklós T; Ajzner É; Muszbek L
Thromb Res; 2017 Oct; 158():93-97. PubMed ID: 28865246
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
Kim SD; Hwang JK; Park SC; Kim JI; Won YS; Yun SS; Moon IS; Park JS
Ann Vasc Surg; 2016 Apr; 32():57-64. PubMed ID: 26802299
[TBL] [Abstract][Full Text] [Related]
14. In vitro secretion deficits are common among human coagulation factor XIII subunit B missense mutants: correlations with patient phenotypes and molecular models.
Biswas A; Thomas A; Bevans CG; Ivaskevicius V; Oldenburg J
Hum Mutat; 2013 Nov; 34(11):1490-500. PubMed ID: 23913518
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
Diz-Kucukkaya R; Hancer VS; Inanc M; Nalcaci M; Pekcelen Y
Lupus; 2004; 13(1):32-5. PubMed ID: 14870915
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers.
Tognazzo S; Gemmati D; Palazzo A; Catozzi L; Carandina S; Legnaro A; Tacconi G; Scapoli GL; Zamboni P
J Vasc Surg; 2006 Oct; 44(4):815-9. PubMed ID: 16945500
[TBL] [Abstract][Full Text] [Related]
17. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
[TBL] [Abstract][Full Text] [Related]
18. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
Shemirani AH; Haramura G; Bagoly Z; Muszbek L
Biochim Biophys Acta; 2006 Aug; 1764(8):1420-3. PubMed ID: 16920044
[TBL] [Abstract][Full Text] [Related]
19. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
Balogh I; Szôke G; Kárpáti L; Wartiovaara U; Katona E; Komáromi I; Haramura G; Pfliegler G; Mikkola H; Muszbek L
Blood; 2000 Oct; 96(7):2479-86. PubMed ID: 11001900
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.
Franco RF; Middeldorp S; Meinardi JR; van Pampus EC; Reitsma PH
Br J Haematol; 2000 Oct; 111(1):118-21. PubMed ID: 11091190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
